Effects of Chronic, Systemic Treatment with the Dopamine Receptor Agonist R-Apomorphine in Partially Lesioned Rat Model of Parkinson's Disease: An Electrophysiological Study of Substantia Nigra Dopamine Neurons

10.4077/CJP.2011.AMM014

Zhen-Hua Gui；Jian Liu；Yong Wang；Umar Ali；Tao Wang；Li Chen

apomorphine ； substantia nigra ； tyrosine hydroxylase ； extracellular recording ； Parkinson's disease

The Chinese Journal of Physiology

54卷2期（2011 / 04 / 01）

96 - 104

英文

Previous studies have suggested that R-apomorphine (R-APO), a non-selective dopamine (DA) receptor agonist, has neuroprotective effects in the experimental models of Parkinson's disease (PD). In this study, we investigated the effects of chronic, systemic treatment with R-APO in the firing activity of substantia nigra pars compacta (SNc) DA neurons in 6-hydroxydopamine (6-OHDA) partially lesioned rats. In the 6-OHDA-lesioned rats treated with vehicle, injection of 6-OHDA (20.1 μg) into the striatum produced a partial lesion causing 41% loss of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the SNc. In the partially lesioned rats, chronic, systemic treatment of R-APO (10 mg/kg/day, s.c., 11 days) attenuated loss of TH-ir neurons in the SNc. The partial lesion of the nigrostriatal pathway and R-APO treatment did not change the firing rate and firing pattern of DA neurons in the SNc of rats. In contrast, the R-APO treatment increased the number of spontaneously active DA neurons of the SNc in the partially lesioned rats, while the lesion decreased the number of spontaneously active DA neurons. In addition, the chronic R-APO treatment decreased the responsiveness of the DA neurons to intravenously administrated R-APO in the partially lesioned rats. These results indicate that chronic, systemic R-APO treatment has the neuroprotective effect, and reverses the decrease in the number of spontaneously active DA neurons in the SNc whereas the treatment induces a reduction in the sensitivity of DA receptors in the SNc to R-APO stimulation in this model.

1. Acheson, A. L.,Zigmond, M. J.,Stricker, E. M.(1980).Compensatory increase in tyrosine-hydroxylase activity in rat-brain after intraventricular injections of 6-hydroxydopamine.Science,207,537-538.
2. Akaoka, H.,Charlety, P.,Saunier, C. F.,Buda, M.,Chouvet, G.(1992).Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors.Neuroscience,49,879-891.
3. Battaglia, G.,Busceti, C. L.,Cuomo, L.,Giorgi, F. S.,Orzi, F.,De Blasi, A.,Nicoletti, F.,Ruggieri, S.,Fornai, F.(2002).Continuous subcutaneous infusion of apomorphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice.Neuropharmacology,42,367-373.
4. Bilbao, G.,Ruiz-Ortega, J. A.,Miguens, N.,Ulibarri, I.,Linazasoro, G.,Gomez-Urquijo, S.,Garibi, J.,Ugedo, L.(2006).Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: Effects of subthalamotomy and levodopa treatment.Brain Res.,1084,175-184.
5. Bozzi, Y.,Borrelli, E.(2006).Dopamine in neurotoxicity and neuro-protection: what do D2 receptors have to do with it?.Trends Neurosci.,29,167-174.
6. Carman, L. S.,Gage, F. H.,Shults, C. W.(1991).Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.Brain Res.,553,275-283.
7. Chen, J. F.,Aloyo, V. J.,Weiss, B.(1993).Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.Neuroscience,54,669-680.
8. Chritin, M.,Blanchard, V.,RaismanVozari, R.,Feuerstein, C.,Agid, Y.,Javoy-Agid, F.,Savasta, M.(1996).DA uptake sites, D1, and D2 receptors, D2 and preproenkephalin mRNAs and fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.Eur. J. Neurosci.,8,2511-2520.
9. Creese, I.,Synder, S. H.(1979).Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.Eur. J. Pharmacol.,56,277-281.
10. Depino, A. M.,Earl, C.,Kaczmarczyk, E.,Ferrari, C.,Besedovsky, H.,del Rey, A.,Pitossi, F. J.,Oertel, W. H.(2003).Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.Eur. J. Neurosci.,18,2731-2742.
11. Fornai, F.,Battaglia, G.,Gesi, M.(2001).Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage.Brain Res.,898,29-35.
12. Gassen, M.,Glinka, Y.,Pinchasi, B.,Youdim, M. B. H.(1996).Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.Eur. J. Pharmacol.,308,219-225.
13. Gassen, M.,Gross, A.,Youdim, M. B. H.(1998).Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.Mov. Disord.,13,242-248.
14. Grace, A. A.,Bunney, B. S.(1983).Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization.Neuroscience,10,301-315.
15. Grunblatt, E.,Mandel, S.,Maor, G.(2001).Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.J. Neurochem.,77,146-156.
16. Guo, H.,Tang, Z. S.,Yu, Y.,Xu, L.,Jin, G. Z.,Zhou, J. W.(2002).Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures.Eur. J. Neurosci.,16,1861-1870.
17. Hollerman, J. R.,Grace, A. A.(1990).The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.Brain Res.,533,203-212.
18. Kirik, D.,Rosenblad, C.,Bjorklund, A.(2000).Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.Eur. J. Neurosci.,12,3871-3882.
19. Nisenbaum, E. S.,Stricker, E. M.,Zigmond, M. J.,Berger, T. W.(1986).Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: Relation to behavioral recovery.Brain Res.,398,221-230.
20. Paxinos, G.,Watson, C.(2005).The Rat Brain in Stereotaxic Coordinates.New York:Academic Press.
21. Pucak, M. L.,Grace, A. A.(1991).Partial dopamine depletions result in an enhanced sensitivity of residual dopamine neurons to apomorphine.Synapse,9,144-155.
22. Rudissaar, R.,Harro, J.,Pruus, K.,Rinken, A.,Allikmets, L.(2008).Repeated administration of the dopaminergic agonist apomorphine: development of apomorphine aggressiveness and changes in the interaction between dopamine D2 receptors and G-proteins.Pharmacol. Rep.,60,827-833.
23. Tepper, J. M.,Sun, B. C.,Martin, L. P.,Creese, I.(1997).Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo.J. Neurosci.,17,2519-2530.
24. Ubeda, A.,Montesinos, C.,Paya, M.,Alcaraz, M. J.(1993).Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines.Free Radical Bio. Med.,15,159-167.
25. Wang, S.,Zhang, Q. J.,Liu, J.,Wu, Z. H.,Wang, T.,Gui, Z. H.,Chen, L.,Wang, Y.(2009).Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT1A receptor stimulation in the rat.Neuroscience,159,850-861.
26. Yuan, H.,Sarre, S.,Ebinger, G.,Michotte, Y.(2005).Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.J. Neurosci. Meth.,144,35-45.
27. Yuan, H.,Sarre, S.,Ebinger, G.,Michotte, Y.(2004).Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.Brain Res.,1026,95-107.
28. Zhang, W. Q.,Tilson, H. A.,Nanry, K. P.,Hudson, P. M.,Hong, J. S.,Stachowiak, M. K.(1988).Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.Brain Res.,461,335-342.
29. Zigmond, M. J.,Acheson, A. L.,Stachowiak, M. K.,Stricker, E. M.(1984).Neurochemical compensation after nigrostriatal bundle injury in an animal-model of preclinical parkinsonism.Arch. Neurol.,41,856-861.
30. Zigmond, M. J.,Berger, T. W.,Grace, A. A.,Stricker, E. M.(1989).Compensatory responses to nigrostriatal bundle injury-studies with 6-hydroxydopamine in an animal-model of parkinsonism.Mol. Chem. Neuropath.,10,185-200.

1. Yang, Li-ye,Xie, Chao,Lin, Lin,Li, Hai-bo(2015).Dopaminergic Facilitation of GABAergic Transmission in Layer III of Rat Medial Entorhinal Cortex.中國生理學雜誌,58(1),46-54.
2. Zhuang, Xiao-sai,Zhu, Feiyan,Zhao, Dan,Zhang, Xiong,Wang, Ning,Wang, Lian,Liu, Yun,Hu, Qiao,Gan, Shi-rui,Chen, Ying,Bao, Qiong-qiong(2012).Association of Common Variants in the Glucocerebrosidase Gene with High Susceptibility to Parkinson's Disease among Chinese.中國生理學雜誌,55(6),398-404.